Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
A Multi-center, Randomized, Double-Blind Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Sichuan Jishengtang Pharmaceutical Co., Ltd.
495 participants
Apr 17, 2023
INTERVENTIONAL
Conditions
Summary
This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Oral, 4 Capsules, BID
Drug: Shugan Jieyu Capsules Placebo, Oral,4 capsules,BID Drug: Placebo, Oral, 1 capsule, BID
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05772104